Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose 13-Cis-Retinoic Acid for Prevention of Second Primaries in Head and Neck Cancer
NCT03370367Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- May 1989
- Primary completion
- Jan 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of isotretinoin in head and neck squamous cell carcinoma (HNSCC), sponsored by Eastern Cooperative Oncology Group. Started May 1989; status: completed.
02
Drugs
isotretinoin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03370367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370367.